Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that patients won't see these numbers and just throw up their hands in fear or resignation.

Dsicover a recent study that compared Stockholm3 with other established biomarkers for prostate cancer screening. Learn more.

Prostate cancer is one of the most common cancers affecting men globally, with African men facing a disproportionate burden of the disease.

A prostate cancer testing event was held recently at the Frome Masonic Hall, where 236 men were tested. Organised by ...

In 2021, just over a third of men ages 55 to 69 had had a PSA (prostate-specific antigen) blood test to check for prostate cancer in the past year. That ...

A man who discovered he had prostate cancer following a free blood test run by a volunteer group has urged other men to get ...

The United Arab Emirates Ministry (UAE) of Health and Prevention has approved Biomerica's Fortel Kidney Disease Test for sale ...

“This test could turn the tide on prostate cancer,” said Prof. Ros Eeles, who led the study. “We have shown that a relatively ...

It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...

Key Highlights: 1. Fortel ® PSA Screening Test Approved by UAE Ministry of Health & Prevention: Biomerica’s Fortel ® Prostate Specific Antigen (PSA) Screening Test has received regulatory approval ...

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly improved detection of clinically important disease. This approach caught ...